Recurrent or Metastatic Esophageal Adenocarcinoma
1 clinical trials · Condition
◉ Watch Recurrent or Metastatic Esophageal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma (NCT07622940) | Beijing Biotech | 2026-03-02 |
Track Recurrent or Metastatic Esophageal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.